Patent · US Active

Glycoconjugates and methods for their use

US10918732B2 · kind B2 · utility

0Cited by
1References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 26, 2019
Grant dateFeb 16, 2021
Priority date
Expiry dateJul 26, 2039

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Certain embodiments are directed to method for synthesizing and using glycoconjugates based on the immunodominant epitope Galα(1,3)Galβ(1,4)GlcNAcα (Galα3LNα).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.